TipRanks on MSN

Karolinska Development portfolio firm SVF Vaccines plans Nasdaq First North Premier listing via Novakand reverse takeover

Karolinska Development AB ( ($SE:KDEV) ) has provided an update. Karolinska Development’s portfolio company SVF Vaccines has signed a non-binding ...
The Manila Times

Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine …

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company ...
The Pharma Letter

SVF Vaccines pursues Nasdaq First North listing via reverse takeover

Swedish life sciences investor Karolinska Development (Nasdaq Stockholm: KDEV) said its portfolio company SVF Vaccines has ...

Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of ...

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand ...